Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
116.50    1.00 (0.87%)
Bid:
116.50
Ask:
117.50
Spread: 1.00 (0.858%)
Market Cap: £257.52m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update re Financing Facility

28 Nov 2008 07:00

RNS Number : 1381J
Queen's Walk Investment Limited
28 November 2008
 



Update on QWIL's Financing Facility

As at 27 November 2008, the Company had drawn €40.5 million against its financing facility and had undrawn availability of €94.5 million. Given current market yields, the Company should be able to achieve its return objectives on new investments without the need for additional leverage. In addition, in today's highly volatile markets, the Company could have been exposed to material change clauses that might have triggered the requirement for the repayment of the facility on unfavourable terms.

In light of these circumstances, the Company has successfully negotiated amended terms on a reduced facility, involving a flexible two year repayment schedule of the outstanding debt and has reduced the risk associated with material change clauses that could have forced a repayment of the debt on unfavourable terms. The Company's cash balance of €16.5 million as at 27 November 2008 and continued cash flows from its investment portfolio support the repayment schedule and the timely redemption of the loan facility. The Company believes that the renegotiated loan facility is more prudent than continued dependence on an unpredictable lending market.

The Company has completed negotiations with its lender and the key elements of the amended facility are summarised below.

The Company has committed to repay the outstanding balance of the facility by October 2011, pursuant to an agreed loan amortisation schedule and will not make any further draw downs. The Company believes it should be able to satisfy the loan amortisation schedule with the €16.5 million of cash currently on the balance sheet and the expected cash flows from its investment portfolio. In addition, at the end of each quarter, the Company has pledged to keep the outstanding balance of the financing facility below the product of the then applicable advance rate ("Applicable Percentage") and the value of the investment portfolio plus cash (the "Borrowing Base"). At present, the Company's Borrowing Base is approximately €62.9 million versus a loan balance of €40.5 million

At the end of each calendar quarter, the Company has agreed a target loan amount ("Target Loan Amount") with the lenders. The Company has also agreed to an Applicable Percentage for every quarter. The Target Loan Amount and Applicable Percentage Schedule are detailed below:

Date

Target Loan Amount

Applicable Percentage for Residuals

31 December 2008

35,000,000

30%

31 March 2009 

33,000,000

30%

30 June 2009 

31,000,000

30%

30 September 2009

28,500,000

30%

31 December 2009

27,000,000

27.5%

31 March 2010 

25,000,000

20%

30 June 2010

12,000,000

20%

30 September 2010

10,000,000

20%

31 December 2010

0

20%

31 March 2011

0

10%

The Applicable Percentage for the Company's investment grade bond portfolio will be 50%, 40%, 30% and 15% for AA and above, A and above, BBB and above and BB and above; rated bonds respectively.

The Target Loan Amount will reduce by €11 million in the event that the Magellan 1 transaction is re-financed by the originator, BCP Millennium, before June 2010. The Applicable Percentage for residuals will reduce to 25% if the Magellan 1 transaction is re-financed by BCP Millennium before 31 December 2009.

The Company has committed to use a percentage of its Free Cash (cash proceeds in a quarter less dividends and operating expenses) to amortise the facility. Prior to the Magellan 1 transaction being refinanced, 75% of the Company's Free Cash will be used to repay the facility. After the Magellan 1 transaction is called, 66% of the Free Cash will be used to repay the debt. Once the outstanding balance of the facility is below €22 million, 50% of the Free Cash will be used to repay the facility. If the outstanding balance of the loan facility is less than the Target Loan Amount on the relevant date, the dividend will be capped at €2.25 million per quarter (or approximately a 19% dividend yield on the share price as at 26 November 2008). If the Company is unable to satisfy the loan amortisation schedule, the dividend will be capped at 8% on the share price prevailing at the end of each quarter. A failure to meet the loan amortisation schedule would not trigger an event of default.

In the event that the balance of the facility is greater than the Borrowing Base, the Company will have 20 business days to remedy the breach. Failure to remedy the breach would constitute an event of default. 

The Company has agreed to more asset specific tests in exchange for limiting the scope of the material change triggers and believes that the investment portfolio can support the amended facility.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGMZMFNMGRZZ
Date   Source Headline
23rd Dec 20117:00 amRNSTransaction in Own Shares
22nd Dec 201112:01 pmRNSFactsheet
22nd Dec 20117:00 amRNSTransaction in Own Shares
21st Dec 20117:00 amRNSTransaction in Own Shares
20th Dec 20117:00 amRNSTransaction in Own Shares
14th Dec 201112:09 pmRNSChange in reporting frequency
14th Dec 20117:00 amRNSTransaction in Own Shares
12th Dec 20117:00 amRNSShare Buy-Back Programme
6th Dec 201110:37 amRNSFactsheet
29th Nov 201110:56 amRNSCondensed consolidated interim financial report
29th Nov 20117:00 amRNSDividend Declaration
29th Nov 20117:00 amRNSDividend Declaration
29th Nov 20117:00 amRNSSecond Quarter Results
18th Nov 20119:17 amRNSFact Sheet
10th Nov 20119:13 amRNSNotice of Results
2nd Nov 20111:57 pmRNSInvestment Manager Fact Sheet
21st Oct 201111:30 amRNSInvestment Manager Fact Sheet
21st Oct 201111:11 amRNSEGM Statement
7th Oct 201112:22 pmRNSInvestment Manager Fact Sheet
7th Oct 201112:19 pmRNSFact Sheet
3rd Oct 20118:26 amRNSChange in share currency denomination
3rd Oct 20117:00 amRNSTop ten holdings disclosure
28th Sep 201111:58 amRNSDirector Declaration
23rd Sep 201110:44 amRNSInvestment Manager Fact Sheet
22nd Sep 20119:33 amRNSEGM Statement
20th Sep 20118:27 amRNSDividend Declaration
20th Sep 20117:00 amRNS1st Quarter Results
16th Sep 201110:56 amRNSResult of AGM
8th Sep 20111:08 pmRNSChange in share currency denomination
31st Aug 20117:00 amRNSDividend Declaration
23rd Aug 20117:00 amRNSCirc re. AGM
22nd Aug 20115:23 pmRNSDirector/PDMR Shareholding
19th Aug 20117:00 amRNSNotice of Results
15th Aug 20117:00 amRNSChange of Name
11th Aug 20118:00 amRNSInterim Management Statement
11th Aug 20118:00 amRNSADMISSION OF CELL SHARES AND ESTIMATED NAV
10th Aug 201112:06 pmRNSEGM Statement
21st Jul 20119:00 amRNSRe Agreement
11th Jul 20112:48 pmRNSPublication of Prospectus
11th Jul 20117:00 amRNSConversion of Securities
1st Jul 20117:00 amRNSTop Ten Holdings
16th Jun 20117:00 amRNSDividend Declaration
16th Jun 20117:00 amRNSFourth Quarter Financial Results
16th Jun 20117:00 amRNSAnnual Financial Report
10th Jun 20113:48 pmRNSDisposal
6th Jun 20117:00 amRNSNotice of Results
1st Jun 20117:00 amRNSDividend Declaration
12th May 201111:57 amRNSDisposal
1st Apr 20117:00 amRNSHolding(s) in Company
15th Mar 20119:50 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.